Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options

S Karakonstantis, EI Kritsotakis… - Journal of Antimicrobial …, 2020 - academic.oup.com
Background The literature on the epidemiology, mortality and treatment of pandrug-resistant
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objectives To …

[PDF][PDF] Pandrug-resistant Gram-negative bacteria. A systematic review of current epidemiology, prognosis and treatment options.

S Karakonstantis, EI Kritsotakis, A Gikas - researchgate.net
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objective: To
consolidate the relevant literature and identify treatment options for PDR GNB infections …

Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options

S Karakonstantis, EI Kritsotakis, A Gikas - Journal of Antimicrobial …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
The literature on the epidemiology, mortality and treatment of pandrug-resistant (PDR) Gram …

Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options.

S Karakonstantis, EI Kritsotakis, A Gikas - 2020 - cabidigitallibrary.org
Background: The literature on the epidemiology, mortality and treatment of pandrug-resistant
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objectives: To …

Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options.

S Karakonstantis, EI Kritsotakis… - The Journal of …, 2020 - europepmc.org
Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology,
prognosis and treatment options. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options

S Karakonstantis, EI Kritsotakis… - Journal of Antimicrobial …, 2020 - academic.oup.com
Background The literature on the epidemiology, mortality and treatment of pandrug-resistant
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objectives To …

Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options

S Karakonstantis, EI Kritsotakis… - Journal of Antimicrobial …, 2020 - eprints.whiterose.ac.uk
Background: The literature on the epidemiology, mortality and treatment of pandrug-resistant
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objective: To …

Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options

S Karakonstantis, EI Kritsotakis… - The Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The literature on the epidemiology, mortality and treatment of pandrug-resistant
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objectives To …

[引用][C] Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options

S Karakonstantis - J Antimicrob Chemother, 2020 - cir.nii.ac.jp
Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology,
prognosis and treatment options | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …